NUVOX PHARMA, L.L.C.
TUCSON, ARIZONA 857196803
$356K
Total Contract Value
5 awards
First Award
Jul 28, 2023
Last Award
Aug 28, 2025
Business Size
small
CAGE Code
51P42
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $356K | 5 |
Contract Awards
2 awards found
75A50123C00034
Department of Health and Human Services
$-393,000
Aug 28, 2025
RESEARCH AND DEVELOPMENT SERVICES FOR DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75A50123C00034
Department of Health and Human Services
$749K
Jul 28, 2023
RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
Business Details
- UEI
- WHNYG96UDLJ8
- CAGE Code
- 51P42
- Address
- 1635 E 18TH ST
TUCSON, AZ 857196803 - Congressional District
- AZ-07
- Phone
- 5206246688
Parent Company
NUVOX PHARMA, L.L.C.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov